Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
Combination targeted therapy (CTT) for PsA shows similar infection risk to standard treatments, with no significant differences in serious or opportunistic infection rates. The study analyzed 82,399 ...
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results